COMMUNIQUÉS West-GlobeNewswire

-
LifeLabs Introduces Three Blood-Based Alzheimer’s Disease Tests, Including Support Services
04/06/2025 -
Frédéric Robert appointed EUROAPI’s Chief Commercial Officer overseeing API Solutions and CDMO activities
04/06/2025 -
EUROAPI nomme Frédéric Robert au poste de Directeur commercial en charge des activités API Solutions et CDMO
04/06/2025 -
Alvotech intends to carry out a private placement of approximately 7.5 million SDRs and ordinary shares
04/06/2025 -
DirectMeds Acquires Autumn DNA, Expanding into Precision-Based Personalized Wellness
04/06/2025 -
Severe Allergic Reactions post Vaccination Discussed in Journal of American Physicians and Surgeons
04/06/2025 -
Ultrack Systems Inc. (OTC: MJLB) Secures 60% Stake in Better Pets, Charging Into the $325 Billion Pet Wellness Industry with Momentum and Market Vision
04/06/2025 -
ALK participates at Jefferies Global Healthcare Conference 2025 in New York
04/06/2025 -
Multiview Financial Software receives HFMA Peer Review designation
04/06/2025 -
Finish Healing First: Ekol Hospitals Urges Medical Travellers to Stay Until Fully Cleared
04/06/2025 -
Highridge Medical Completes the Sale of its Bone Healing Division to Streamline Strategic Focus and Innovation in Spine
04/06/2025 -
Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma
04/06/2025 -
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
04/06/2025 -
60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format
04/06/2025 -
Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB-107)
04/06/2025 -
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
04/06/2025 -
Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development
04/06/2025 -
ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance
04/06/2025 -
Synergy CHC Announces New $20 Million Long-Term Credit Facility
04/06/2025
Pages